Zeo ScientifiX (ZEOX) Cash from Discontinued Operations (2015 - 2016)
Zeo ScientifiX (ZEOX) posted quarterly Cash from Discontinued Operations of 13620.0 for Q4 2016, up 112.66% year-over-year from 6404.66 in Q4 2015, and up 194.05% quarter-over-quarter from 14482.0 in Q3 2016.
Zeo ScientifiX (ZEOX) Cash from Discontinued Operations (2015 - 2016) Analysis & Trends
Zeo ScientifiX's Cash from Discontinued Operations history runs 2 years deep, the most recent figure standing at 13620.0 for Q4 2016.
- In Q4 2016, Cash from Discontinued Operations rose 112.66% year-over-year to 13620.0; the TTM figure through Oct 2016 stood at 2098.0 (up 102.76% YoY), while the FY2016 annual figure was 2098.0, up 102.76% from the prior year.
- Cash from Discontinued Operations for Q4 2016 stood at 13620.0, up from 14482.0 in the prior quarter.
- The five-year high for Cash from Discontinued Operations was 19049.0 in Q3 2015, with the low at 107603.0 in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2016 | 13,620.00 |
| Oct 31, 2016 | 13,620.00 |
| Jul 31, 2016 | -14,482.00 |
| Jul 31, 2016 | -14,482.00 |
| Apr 30, 2016 | 1.00 |
| Apr 30, 2016 | 1.00 |
| Jan 31, 2016 | 2,959.00 |
| Jan 31, 2016 | 2,959.00 |
| Oct 31, 2015 | -107,603.00 |
| Oct 31, 2015 | -107,603.00 |
| Jul 31, 2015 | 19,049.00 |
| Jul 31, 2015 | 19,049.00 |
| Apr 30, 2015 | 11,811.00 |
| Apr 30, 2015 | 11,811.00 |
| Jan 31, 2015 | 808.00 |
| Jan 31, 2015 | 808.00 |